RhumbLine Advisers’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.04M | Sell |
114,533
-14,662
| -11% | -$389K | ﹤0.01% | 1663 |
|
2025
Q1 | $3.12M | Sell |
129,195
-1,032
| -0.8% | -$24.9K | ﹤0.01% | 1602 |
|
2024
Q4 | $5.24M | Sell |
130,227
-218
| -0.2% | -$8.77K | ﹤0.01% | 1397 |
|
2024
Q3 | $8.26M | Buy |
130,445
+3,187
| +3% | +$202K | 0.01% | 1160 |
|
2024
Q2 | $6.75M | Sell |
127,258
-16,845
| -12% | -$893K | 0.01% | 1230 |
|
2024
Q1 | $11.8M | Buy |
144,103
+14,911
| +12% | +$1.22M | 0.01% | 967 |
|
2023
Q4 | $2.4M | Sell |
129,192
-1,696
| -1% | -$31.6K | ﹤0.01% | 1819 |
|
2023
Q3 | $1.45M | Buy |
130,888
+3,059
| +2% | +$33.9K | ﹤0.01% | 2017 |
|
2023
Q2 | $2.07M | Buy |
+127,829
| New | +$2.07M | ﹤0.01% | 1888 |
|
2022
Q2 | – | Sell |
-92,483
| Closed | -$277K | – | 3243 |
|
2022
Q1 | $277K | Sell |
92,483
-16,399
| -15% | -$49.1K | ﹤0.01% | 2666 |
|
2021
Q4 | $501K | Sell |
108,882
-646
| -0.6% | -$2.97K | ﹤0.01% | 2509 |
|
2021
Q3 | $688K | Buy |
109,528
+3,378
| +3% | +$21.2K | ﹤0.01% | 2406 |
|
2021
Q2 | $636K | Sell |
106,150
-8,601
| -7% | -$51.5K | ﹤0.01% | 2444 |
|
2021
Q1 | $726K | Sell |
114,751
-5,510
| -5% | -$34.9K | ﹤0.01% | 2324 |
|
2020
Q4 | $677K | Buy |
120,261
+13,578
| +13% | +$76.4K | ﹤0.01% | 2314 |
|
2020
Q3 | $621K | Sell |
106,683
-14,089
| -12% | -$82K | ﹤0.01% | 2187 |
|
2020
Q2 | $871K | Buy |
120,772
+11,414
| +10% | +$82.3K | ﹤0.01% | 2099 |
|
2020
Q1 | $512K | Buy |
109,358
+8,750
| +9% | +$41K | ﹤0.01% | 2153 |
|
2019
Q4 | $807K | Buy |
100,608
+986
| +1% | +$7.91K | ﹤0.01% | 2175 |
|
2019
Q3 | $685K | Buy |
99,622
+7,803
| +8% | +$53.7K | ﹤0.01% | 2209 |
|
2019
Q2 | $762K | Buy |
91,819
+14,062
| +18% | +$117K | ﹤0.01% | 2176 |
|
2019
Q1 | $773K | Buy |
77,757
+5,017
| +7% | +$49.9K | ﹤0.01% | 2147 |
|
2018
Q4 | $556K | Buy |
72,740
+27,799
| +62% | +$212K | ﹤0.01% | 2245 |
|
2018
Q3 | $783K | Buy |
44,941
+3,304
| +8% | +$57.6K | ﹤0.01% | 2105 |
|
2018
Q2 | $395K | Buy |
+41,637
| New | +$395K | ﹤0.01% | 2410 |
|